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ABSTRACT 
This study compares the effects of three sympathomimetic agents used in 
over-the-counter ocular decongestants, tetrahydrozoline, phenylephrine and 
naphazoline on intraocular pressure, anterior chamber angle and pupil diameter 
in normal healthy adult eyes. Both short term effects, monitored at 15 minutes, 
30 minutes and 45 minutes following initial drop instillation, and long term 
effects measured for 96 hours during habitual use were studied. Only one pro­
duct, Visine, which contains tetrahydrozoline, produced a significant change 
in the measured parameters. Visine lowered the intraocular pressure an average 
of 1.9 rmnHg thirty minutes after instillation. 
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INTRODUCTION 
In today's youth oriented society, the indescriminate use of over-the-
counter drugs is common-place in the search for social acceptance. Natural 
body chemistry is masked and modified with such preparations as deodorants, 
aspirin, antacids and antihistamines with little regard for the physiological 
side effects. Presently, the general public's use of ocular decongestants 
to whiten the eyes is being encouraged by energetic mass-media techniques. 
The wide use of these preparations could cause undesirable changes in the 
physiological state of the eye in a significant portion of the population. 
Presently available are ouclar decongestants containing one of three 
sympathomimetics: tetrahydrozoline-HCl, nephazoline-HCl and phenylephrine­
HCl .1 Sympathomimetics mimic sympathic stimulation to the eye and thus could 
be expected to cause pupil dilation as well as whitening of the eyes due to 
vasoconstriction. As a consequence of pupil dilation, an individual with a 
narrot-l angle could experience elevated intraocular pressure and an acute 
2 
glaucoma attack due to angle closure. Labels on these drugs warn against 
use by individuals with suspected or confirmed glaucoma. In contrast, some 
sympathomimetics have been observed to lower intraocular pressure although 
3 
the mechanism is not understood. 
Several studies on the effects of ocular decongestants on conjunctival 
·vasoconstriction have been reported. Researchers have used tetrahydrozoline-
HCl and phenylephrine-HCl in concentrations greater than the 0.05% to 0. 125% 
found in over-the-counter preparations and concluded that in the absence of 
narrot·.7 anterior angle, there was no significant increase in intraocular pres-
4 5 6 
suL·e. ' ' Hrnvever, there are no studies which looked specifically at the 
changes in intraocular pressure and anterior angle in normal eyes after in-
st�llation of ocular decongestants. Neither are there comparative studies of 
- 2 -
these three agents. 
Some studies of o cular decongestants have used the contralateral eye as 
h f . h . d 4'5'6 . d h ff 
4 
t e standard o comparison or t ere was none cite • Weiss an S a ·er 
6 
used a Schoitz tonometer to measure intraocular pressure and Mengel made 
reference to tonography. 
This study compares the effects of three sympatho mimetic agents, tetra-
hydro zo line, phenylephrine and naphazo line, on intraocular pressure, anterior 
angle and pupil diameter in normal healthy adult eyes. Changes from the base 
line values measured in the same eyes before drug instillation were compared 
using standard instrumentation. 
MATERIALS AND METHODS 
Product Survey 
A telephone survey o f  three large wholesale pharmaceutical outlets was 
conducted to make a qualitative determination o f  the most widely used trade-
name representative of each sympathomimetic agent used in o ver-the-counter 
ocular decongestants. A large retail outlet Ivas also contacted to substan-
tiate the results of the telephone survey. Visine, Prefrin Liquifilm and 
Clear Eyes were found to be the rrost popular representatives containing tetra-
hydrozoline, phenylephrine and naphazoline respectively. Therefore, these 
products were selected for the study. Lyteers was very similar in basic 
ingredients and preservatives to these products but without a decongestive 
agent. It was, therefore, chosen as the control. The characteristics of the 
agents sel ected for use are suzmnarized in Table 1. 
INSERT TABLE 1 ABOUT HERE. 
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Subjects 
Forty subjects were selected from the adult student and staff population 
at Pacific University. They v;ere screened using the following criteria: 
1) presence of light irides, 2) absence of ocular pathology, 3) good general 
heal th, 4) non contact lens wearer, 5) anterior angle ratio � or wider as 
7 determined with biomicroscope using the method outlined by r·lalker, 6) �'1ithin 
the normal range of intraocular pressure (8 to 20 mmllg} as determined with a 
non contact tonometer. 
Procedure 
To establish the physiological base lines, intraocular pressure, anterior 
angle ratio and pupil diameter were measured on each subject on two separate 
days. These base line measurements on each subject were used as the standards 
of comparison for subsequent measures of these parameters. The subjects were 
then randomly placed in four groups, ten subjects per group, and given one of 
the four products, Visine, Prefrin, Clear Eyes or Lyteers in double blind 
fashion. After an initial drug instillation of two drops in each eye by self 
administration, the subjects 1"1ere rronitored for short term drug effects by 
measuring intraocular pressure, anterior angle ratio and pupil diameter at 
15 minutes, at 30 minutes and again at 45 minutes. Subjects were then placed 
on a three times per day schedule of self instillation and asked to return 
after 48 hours and again after 96 hours for data collection. This allowed for 
the study of prolonged accumulative drug effects. 
All intraocular pressure measurements were taken with the American Optical 
Non Contact Tonometer. This instrument was selected for its repeatable meas-
urement capability 1"1ithout the use of any anesthetic. Calibration was easily 
checked before each use. Pupil diameter was determined using a Mentor bio-
microscope i-.rith eyepiece reticule modified from a seven power magnifier. Using 
- 4 -
this arrangement, pupil diamter could be measured to within 0.05mm. Pupil 
diameter measurements were done norwal to the eye while subjects were asked 
to fixate on a distant non-detailed target with the opposite eye. Controlled 
illumination was provided by placing a 25 watt soft-�n1ile incandescent lamp 
in a white diffusing reflector immediately above the instrument and by using 
no other room or instrument illumination. 
Anterior angle ratio was determined using the method described by fialker. 
7 
An optic section was viewed with the illumination directed normal to the temp­
oral corneolimbal junction and the viewing system 60 degrees from the illumin­
ation system. The width of the cornea to iris shadow was compared to the 
thickness of the cornea. A ratio of 1/1 is considered wide open and 1/4 is 
considered marginally narrow. Low level instrument illumination was used with 
no room illumination. Lo�-; power objectives were used both in this and the pupil 
diameter measurement. As some subjectivity was necessary to make these meas­
urements, one experimentor made all observations. All intraocular pressure, 
anterior angle and pupil diameter measurements were made on the right eye only. 
The following was done to reduce the confounding factors in the experi­
ment: 1) all drug samples in each group were from the same lot, 2) each sub­
ject's measurements were taken at the same time of day, 3) all measurements 
t11ere made on the same standardized instruments, 4) all measurements were made 
by the same observer, 5) subjects were instructed to self administer the drug 
in the same manner, two drops in the lower fornix of each eye with the lower 
lid pulled away to form a pocket followed by closed eyes for 15 to 20 seconds, 
6) the drug samples were dispensed randomly and in a double blind fashion, 
and 7) the 48 hour and 96 hour measurements were taken with a minimum of two 
hours separation between drug instillation and measurement to avoid possible 
short term drug effect. 
- 5 -
The physiological base line data o n  the four subject gro ups were com-
pared using single factor analysis of variance to insure population uniform-
ity. The individual subject base line measurements were subtracted fro m the 
subsequent intraocular pressure, anterior angle r atio and pupil diameter read-
.in gs in each time frame. Using single factor analysis o f  variance, the means 
of these changes in the three groups given products containing sympathomimetics 
were statistically compared to the mean of the changes observed in the contro l 
group given the artificial tears. 
8 
Newman Keuls' Nul tiple Range Test �ras used 
for final comparison of data found to be significant with the analysis o f  var-
iance. The pro bability level used was 95% in both the analysis of variance and 
the Newman Keuls' test. 
RESULTS 
The mean intraocular pressure of the subject population was 13.2 mmHg 
with a r ange B.5 to 19.8 mmHg; the mean anterio r angle ratio was 1.0 with a 
range 0. 6 to 1. 7; and the mean pupil diameter was 4. 9 mm with a range 2. 7 to 
6 .6 mm .  The physio logical base line measurements of intraocular pressure, 
anterio r angl e and pupil diameter for the four study groups were found not 
statistically different (P<0.05). 
The means and ranges of the changes produced in intraocular pressure, 
anterior angle and pupil diameter by the four pharmaceutical agents are shown 
in Tables 2, 3 and 4. 
J.SSERT TABLES 2, 3 and 4 ABOUT HERE. 
As can be seen, all changes in intraocular pressure, anterior angle and 
pupil diameter are small. None of the sympathomimetics had a significant ef-
feet on anterior angle or pupil diameter at the times studied. The o nly signif-
- 6 -
icant change in intraocular pressure was measured after instillation of tetra­
hydrozaline. Tetrahydrozoline lowered the intraocular pressure by an average 
of 1.9 mmHg 30 minutes after instillation (P<0 .05). This significant differ­
ential effect can be seen in Figure 1. 
INSERT FIGURE l ABOUT HERE. 
Although changes in intraocular pressure caused by tetra hydrozoline at 
other than 30 w�nutes and by phenylephrine and naphazoline at all times were 
not significantly different than those of the control group, several trends 
can be seen. Phenylephrine closely mimics the control over the time observed. 
'I'etrahydrozoline produced a lower average intraocular pressure than the control 
at all times observed. In contrast, naphazoline produced a higher average intra­
ocular pressure than the control at all times observed. 
DISCUSSION 
Up to nov.1, no good study has been done comparing over-the-counter ocular 
decongestants. The use of the Schiotz tonometer or tonography for intraocular 
pressure measurement or the contralateral eye as standard of comparison is less 
than ideal. Ple have used the American Optical Non Contact tonometer to avoid 
the use of any anesthesia and corneal trauma interent in methods of previous 
studies which used Schiotz tonometry and tonography. rve also feel better con­
trol is achieved by the comparison of changes in intraocular pressure, either 
increased or decreased to the subjects own base line pressure and not that of 
the contralateral eye because of the possible sympathetic physiological re-
None of the sympathomimetics found in the over-the-counter ocular decon­
qestants studied produced a significant change in the intraocular pressure, 
- 7 -
anterior angle ratio or pupil diameter of the normal healthy eye during the 
range of 96 hours except tetrahydrozoline. The effect of tetrahydrozoline was 
to lower the intraocular pressure 30 minutes after instillation by an average 
of 1.9 mmHg. The range included an individual with as much as 3.8 mmHg reduction. 
This could have clinical significance if tonometry were performed 30 minutes af­
ter an ocular decongestant containing tetrahydrozol.ine was used by the patient 
because it would be possible for a borderline high intraocular pressure to be 
found normal as a direct result of pressure depression due to the drug. 
As determined by our study, habitual use of those preparations by sub­
jects with normal healthy eyes does not appear to produce an accumulative ef­
fect through 96 hours if the recommended dosage level is not exceeded. Hov1ever, 
individuals most prone to use these preparations could well exceed the recom­
manded dosage for a variety of reasons. Contact lens wearers or individuals 
·v.rith eye irritation including abraded corneas may instill more than the recom­
mended dosage in an attempt to relieve the irritation. In addition, these 
individuals could be predisposed to more rapid drug up-take bacause of discon­
tinuities in the corneal epithelium. Therefore, the trends 1-1e observed in the 
normal subjects in this study could be greatly exaggerated by a combination of 
drug over-use and tissue exacerbation. 
f'le feel that even rvith the low concentrations found in these over-the­
counter preparations, significant detrimental ocular physiological changes 
can occur with repeated or excessive use. Further study needs to be under­
taken on the effects of ocular decongestants on irritated eyes. 
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Table 1. Constituents of Tested Pharmaceuticals. 
Preparation Sympa thomimetic Preservative 
Vi sine Tetrahydrozoline-HCl Benzalkonium 
0.05�6 Chloride 0. 01% 
(EDTA). 0.1% 
Clear Eyes Naphazoline-HCl Benzalkonium 
0.012�6 Chloride 0.01% 
(EDTA) 0.1% 
Prefrin Liquifilm Phenylephrine-HCl Benzalkonium 
0 .129; Chloride 0. 00496 
Lyteers Benzalkonium 
(Control) Chloride 0. 0196 
(EDTA) 0.05% 
1 2 
Buffer 
1 
1 
2 
Buffers: Other ingredients: 
Other 
Ingredients 
E 
B 
C,D 
A,E,F 
.L. 
2 
Boric acid + Sodium borate 
Sodium phosphate + Sodium biphosphate 
A Hydroxypropylmethylcellulose 
B Methylcellulose 
C Polyvinyl alcohol 
D = Antipyrine 
E = NaCl 
F = KCl 
Table 2. ChangGs in Intraocular Pressure After Instillation of Pharmaceutical Agents. 
Time Control Tetrahydroz- Phenylephrine Naphazoline 
(Minutes) (Lyteers) oline (Vi sine) (Prefrin) (Clear Eyes) 
x 0.3 -0.B 0.0 0 .2 15 
-2.0 +1.5 -4.0 to +O.B -4.2 to +2.5 -2.6 to +2.0 Range to 
30 x -0 .1 -1.9 -0.2 0.4 
Range - 2 . l to +1.5 -3 .8 to +0.8 -1 .8 to +1.2 -2.0 to +2.5 
x -0.4 -1.4 -0 .6 -0.2 45 Range -2.5 to +2.5 -3 .8 to +0.3 -3.0 to +1.0 -1.6 to +1.8 
x -0.5 -1.2 -0.3 -0 .4 2900 
Range - 3 . 0 to +1.5 -3.5 to +1.8 -1.8 to +l .O -2.5 to +2.6 
x -1.6 -1.4 -1. 7 -2.5 5300 -6.5 to +0.6 -4.4 to +1.5 -3.2 to +0.8 -6.5 to -0 .2 Range 
Table 3. Changes in Anterior Angle After Instillation of Pharmaceutical Agents. 
Time Control Tetrahydroz- Phenylephrine Naphazoline 
(Minutes) (Lyteers) oline (Vi sine) (Prefrin) (Clear Eyes) 
15 
x 0.0 -0.1 o.o o.o 
Range -0.l to +0.2 -0.3 to +0.2 -0.3 to +0.2 -0.2 to +0.2 
x o.o o.o 0. 0 0.0 30 
Range -0.2 to +0.2 -0.2 to +0.2 -0.2 to +0.2 -0.2 +0.2 to 
t-15 x 0.0 0.0 o.o 0.0 
Range -2.2 to +0.2 -0.2 to +0.2 -0.2 to +0.2 -0.2 to +0.2 
2900 x 0.0 0.0 0.1 -0.l 
Range -0.3 to +0.2 -0.4 to +0.3 -0.2 to +0.2 -0.4 to +0.2 
5800 x 0.0 0.1 0.3 -0.l 
Range -0.2 to +0.2 -0.4 to +0.3 -0.2 to +1.4 -0.4 to +O.l 
Table 4. Changes in Pupil Size After Instillation of Pharmaceutical Agents. 
Time Control Tetrahydroz- Phenylephrine NaphazoLine 
O'Jinutes) (Lyteers) oline (Visine) (Prefrin) (Clear Eyes) 
15 
x -0.2 -0.4 -0.6 -0.1 
Range -0.9 to +0.6 -1.0 to 0.0 -2.0 to +0.5 -0.8 to +0.8 
30 
x -0.3 -0.5 -0.4 -0.6 
Range -1.1 to +0.6 -1.2 to o.o -1.4 to +0.7 -1.1 to +0.2 
45 x 0.1 -0.4 -0.3 -0.5 
Range -1.2 to +3.5 -1.0 to +0.5 -1.8 to +1.1 -1.1 to +0.4 
2900 x -0.4 0 .0 -0.5 0.0 
Range -0.9 to +0.2 -0.2 to +0.4 -1.1 to +0.5 -1.5 to +1.4 
5800 
x -0.3 -0.2 -0.3 0.0 -
Range -1.6 to +0.9 -1 . 0 to +0 . 4 -1.4 to +0.6 -0.4 to +0.6 
0.4 
0.2 
0 
- 0.2. 
-0.4 
-0.6 
-0.8 
-1.0 
-1.2 
-1.4 
-1.6 
-1.8 
-2.0 
-
----- -----
----
_. .-:.. :.- .-
--
E: :::- ---- -------
,, ' 
' ' ' 
o 
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', ' ' ' ' ' ' 
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15 
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FIGURE 1 .  Short Term Changes in Mean Intraocular Pressure 
Appendix A 
DATA SUMMARY 
CONTROL (LYTEERS) 
Time I.O.P. A.A. Pupil Size 
(Minutes) 
Mean 0.32 0.023 -0.}85 
SS 9 . 901 0.07'1 2.895 
15 Range -2.0 to +1.5 -.1 to +.22 -0.9 to +.55 
SD 0.995 0.086 0.538 
Mean -0.13 -0.002 -0.315 
SS 16 . 706 0.102 2.225 
30 Range -2.l to +1.5 -0.17 to +.22 -1.l to +.55 
SD 1.292 0.100 0 .471 
Mean -o. 39 0.025 0.07 
SS 21.354 0.152 15.586 
45 Range -2.5 to +2.5 -.15 to +.25 -1.2 to ·f-3.5 
SD 1.461 0 . 123 1.248 
Ne an -0.505 -0.022 -0.361 
SS 16 . 502 0.280 1.864 
2900 Range -3.0 to +1.5 -0.3 to +.25 -0.9 to +.2 
SD 1 . 284 0.167 0.432 
!Jean -1.655 0 . 013 -0.3 
SS 47 . 317 0.184 B . 745 
5800 Range -6.5 to +.65 -.2 to +.25 -1.6 to +.9 
SD 2.175 0.135 0.935 
TETRAHYDROZOL INE-I-ICl (VIS INE) 
Time I. O.P. A.A. Pupil S.ize 
(Minutes) 
Mean -0.765 -o .07 -0.44 
SS 17.745 0.19709 1.084 
15 Range -4.0 to +.75 -. 31 to +0.2 -1.0 to +O .05 
SD 1.332 0.140 0.329 
Mean -1.885 -0.042 -0.5 
SS 12.255 0.14856 1.25 
30 Range -3. 75 to +0.75 -.19 to +.2 -1.25 to o.o 
SD 1.107 0.122 0.353 
Mean -1.41 -0.009 -0.38 
SS 15.344 0 .14229 2.186 
45 Ranri_e -3.75 to 0.3 -0.19 to +.12 -1.05 to +0.5 
SD 1.238 0.119 0.467 
Mean -1.185 -0.047 a.a 
SS 20.005 0. 32981 0. 31 
2900 Range -3.5 to +l. 75 -.41 to +.32 -.2 to +.4 
SD 1.414 0.181 0.176 
Mean -1. 415 -o .077 -0.21 
SS 29.745 0.44481 2.129 
5800 Range -4.45 to +.25 -.41 to +.27 -.95 to +.40 
SD 1.724 0.211 0.461 
PHENYLEPHRINE-HCl (PREFRIN) 
Time I.O. P. A.A. Pupil Size 
(Minutes) 
Mean 0.03 -.005 -0.55 
SS 41.281 0.231 4.45 
15 Range -4.25 to +2.5 -0.3 to +.2 -1.95 to +0.5 
SD 2.031 0.152 0.667 
Mean -0.22 0.049 -0.42 
SS 12.686 0.202 4.911 
30 Range -1.B to +l.25 -.23 to +.25 -1.45 to +0.7 
SD 1.126 0.142 0.700 
Mean -0.65 0.013 -0.34 
SS 14.305 0.244 6.089 
45 Range -3.0 to +l -0.23 to +0.19 -1. 75 to +1.1 
SD 1.196 0.156 o. 780 
Mean -0.32 0.052 -0.457 
SS 11.616 0.1.56 2.328 
2900 Range -1. 75 to +l -0.2 to +0.19 -1.12 to +.5 
SD 1.077 0.124 0.482 
Mean -1. 73 0.295 -0.32 
SS 15.091 2.786 3.401 
5800 Range -3.25 to +.75 - .17 to +1.35 -1.4 to +0.55 
SD 1.228 0.527 0.583 
NAPHAZOLINE-HCl (CLEAR EYES) 
Time I .O.P. A.A. Pupil Size 
(Minutes) 
Mean -0.1966 -0.036 -0.060 
SS 18.571 0.294 1.576 
15 Range -2.6 to +2 -.25 to +.22 -.85 to +.75 
SD 1.362 0 .171 0.396 
Mean +0.3744 -0.026 -0.566 
SS 15.737 0.246 1.505 
30 Range -2 to +2.5 -.25 to +.22 -1. 1 to + .. ]5 
SD 1.254 0.157 0.388 
Mean -0.203 -0.0218 -0.455 
SS 11. 667 0.248 _l. 937 
45 Range -1.6 to +l. 8 -0.25 to +.22 -1.l to +0.35 -
SD 1.080 0 . 157 0.440 
Mean -0.386 -0.117 0.005 
SS 16.128 0.236 5.677 
2900 Range -2.5 to +2.6 -.35 to +.22 -1.5 to +1.35 
SD 1.269 0.153 0.753 
Mean -2.47 -0.108 0.033 
SS 34.711 0.152 1.075 
5800 Range - 6 . 5 to -0.2 -0.35 to +.07 -.45 to +0 . 6 -
SD 1.863 0 • .  123 0.327 
Appendix B 
STATISTICAL DATA TOTAL POPULATIO� 
Analysis of Variance on Group Population Base Line Data: 
Parameter Control 'l'etrahydrozoline Phenylephrine Naphazoline 
Group Group Group Group 
x 12.51 13. 71 12.72 13.78 I.O. P. SS 65.58 80 .13 29.56 70.86 
x 1.05 1.14 0 . 95 1.02 A.A. 
SS 0.80 o. 70 0.41 0.35 
P.D. x 5.22 5.06 5.18 4.58 
SS 7. 77 8.19 4.99 8.04 
Parameter Sum Sq. d.f. Hean Sq. F. ratio 
I.O.P. 
Among 13 .07 3 4.36 0.66 
�vi thin 246 .13 36 6.6 
Among 0.19 3 0.063 1 A.A. 
Within 2.26 36 0.063 
P.D. 
Among 2.58 3 0.86 1.06 
�ii thin 29.01 36 0.81 
F0
9
5(3,36) = 2.86 There is no significance indicated in 
this data at the p=0.05 level. 
Appendix C 
STATISTICAL ANALYSIS OF PHYSIOLOGICAL EFFECTS 
Analysis of Variance on Intraocular Pressure Data: 
Time Control Tetrahydroz- Phenylephrine Naphazoline Grancl Ncan 
(Minutes) Lyteers) oline (Visine) (Prefrin) (Clear Eyes) 
15 
x • 32 -. 765 .03 .1966 - "05<16 
SS 9.901 17 . 745 41.281 18 . 571 
30 x -.13 -1.885 -.22 .3744 - . 4652 SS 16. 706 12.255 12 . 686 15.737 
45 x 
-. 39 -1.41 -.65 -.203 -. 6 6 3 2  
SS 21. 354 15.344 14.305 11. 667 
2900 
x -.505 -1.185 -.32 -.386 -.599 
SS 16.502 20.005 11.616 16.128 
5800 
x -1.655 -1.415 -1. 73 -2.4 7 - 1 . 8 .Z B  
SS 4 7. 317 29.745 15.091 34. 711 
Time Sum Sq. d.f. Mean Sq. F ratio 
(Minutes) 
15 
Among 7 .1525 3 2.3842 0.9809 
Within 87.498 36 2.4305 
30 
Among 28.932 3 9.6441 6.050 
Within 57.384 36 1. 5940 
45 Amonq 8.4431 3 2.8144 1.616 7 r<lithin 62.6 70 36 1.7408 
2900 
Among 4. 7544 3 1.5848 0.8880 
rvi thin 64.251 36 1.7848 
5800 Amo
n� 6.2182 3 2. 072 7  0.5882 
Within 126.86 36 3.5240 
F095(3,36) 
= 2.86 30 minute data is significant. Post hoc 
analysis of this time frame was done to isolate the effective 
agent. 
Post Hoc Analysis (Ne\\'lT!an Keuls ' ) of the 30 .Minute Intraocular Pressure Data: 
Crit. Diffs qr J Mean Sq. Within'groups 
n per cell 
r qr .95
(3,36) Standard Error 
2 2.87 
3 3.46 
4 3.82 
Tetrahydrozoline vs. Control: 
Phenylephrine vs. Control: 
Naphazoline vs. Control: 
0. 399 
" 
" 
Difference of means 
Cri t. Di ff. J 
Difference of means 
Crit. Diff.2 
1. 755 
1. 380 
0.090 
1.145 
Difference of means 0.504 
Crit. Diff.
2 
= 1.145 
Tetrahydrozoline vs. Phenylephrine: 
Difference of means = 
Crit. Diff. 2 
Phenylephrine vs. Naphazoline: 
Difference of means = 0.594 
Cit. Diff.3 1.380 
Naphazoline vs. Tetrahydrozoline: 
Difference of means 
Crit. Diff. 4 
2.259 
1.524 
1.594 
10 
= q -r 0.399 
Crit. Diff. 
1.145 
1.380 
1.524 
(Significant} 
(Significant) 
(Significant) 
Indicated significance is at the p = 0.05 level. 
of Variance on Anterior Angle Date: 
Control Tetrahydroz- Phenylephrine Naphazoline Grand i'Jean 
(Lyteers) 
.023 
. 07441 
-.002 
. 1 0216 
.025 
.15205 
-.022 
.28036 
.0133 
.1838 
Time 
(Ninutes) 
15 
30 
45 
2900 
5800 
oline 
Among 
�vi thin 
Among 
rvi thin 
Am:Jng 
Within 
AI1KJng 
ivi thin 
Among 
f'lithin 
F. 9 5 ( 3, 36} 2.86 
(Visine) (Prefrin) (Clear Eyes) 
-.071 -. 005 -.0366 
.19709 .23105 .294 
-.042 .049 -.026 6 
. 14856 .20189 .246 
-.009 . 013 -.0218 
.14229 .24421 .2481 3 
-.047 .052 -.117 
.32981 .15596 .23621 
-.077 .295 -.1088 
.44481 2.7866 .15189 
Sum Sq. d.f. Nean Sq. F ratio 
.04928 3 •. 0 1642 .74233 
• 79655 36 . 02213 
.04760 3 .01587 .81762 
.69861 36 .09406 
.01340 3 .00447 .20440 
.78668 36 .02 185 
. 14597 3 .04866 1. 7475 
1.0023 36 .02784 
1.0122 3 .33739 3. 4049 
3.5672 36 .09909 
5800 minute (96 hour) data is signifi-
cant at the p = 0.05 level. Post hoc analysis of this time 
fraITE was done to isolate the effective agent. 
- .. 0224 
-.0054 
.0013 
-. 0 3 3 5  
.0306 
'l 
Post Hoc Analysis (Neiv1nan Keuls') of the 5800 f.linute Anterior Angle Data: 
Crit. diffs qr J Nean Sq. rv.i thin groups 
n per cell 
r q 05
(3,36) r. _, 
2 2.87 
3 3.46 
4 3.82 
Tetrahydrozoline vs. Control: 
Phenylephrine vs. Control: 
Naphazoline vs. Control: 
Standard Error 
.0995 
If 
" 
Difference of means 
Crit. Diff.
2 
Difference of means 
Crit. Diff.
2 
Difference of means 
Crit. Diff.
3 
Tetrahydrozoline vs. Phenylephrine: 
Difference of Means 
Cr i t. Di ff. 
3 
Phenylephrine vs. Naphazoline: 
Difference of means 
Crit. Diff.
4 
Naphazoline vs. Tetrahydrozoline: 
Difference of means 
Crit. Diff.
2 
Indicated significance is at the p 
I �09909 
� 10 
Crit. Diff. 
0.090 
0.285 
0.282 
0.285 
0.122 
0.344 
0.3 72 
0.344 
0.404 
0.380 
0.032 
0.285 
0.285 
o. 344 
0.380 
(Significant) 
(Significant) 
0. 05 level. 
I 
I I 
l .j J 
I 
I 
Analysis 
T.ime 
(Ninutes) 
15 
30 
45 
2900 
5800 
of 
x 
SS 
x 
SS 
x 
SS 
x 
SS 
x 
SS 
Variance on Pupil Diameter Data: 
Control Tetrahydroz- Phenylephrine Naphazol_ine Grand !'·Jean 
(Lyteers) oline (Vi sine) (Prefrin) (Clear Eyes) 
-.185 -.440 -.550 -.0604 -.3088 
2.8952 1.084 4.45 1.5766 
-. 315 -.500 -.420 -.566 -. 4502 
2.2252 1.25 4.911 1.5050 
.0 70 -.380 -.340 -.455 - . 2762 
15.586 2.186 6.089 1.9372 
-. 361 o -. 45 7 .005 -. 2 0 3 2  
1.8639 0.310 2.3284 5. 6772 
-.300 -. 210 -.320 .033 -._l992 
8.745 2 .129 3.401 1.0750 
Time Sum Sq. d.f. Mean Sq. F ratio 
(Minutes) 
15 Among 
1.5242 3 . 50807 1.8280 
Within 10.006 36 . 2 7 794 
30 
Among .35081 3 .11694 . 42559 
rlithin 9.8913 36 • 2 7476 
45 
Among 1.666 7 3 .55556 . 7 7530 
Within 25.798 36 • 71662 
2900 
Among 1. 7395 3 .57983 2.0506 
Within 10.180 36 .28276 
5800 
ATOC>ng . 78 786 3 .26262 .61590 
Within 15.350 36 .42638 
F.95 
(3,36) = 2.86 There is no significance indicated 
in this data at the p = 0.05 level. No post hoc analysis 
performed. 
Appendix D 
STUDY RECORD FOR.MS 
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MASTER RECORDING SHEET 
FOR 
C OMPARATIVE STUDY OF 0-T-C TOPICAL OPHTHALMIC DECONGESTANTS 
SUBJECT :��---������--_,..� ....... -
DATE TIME I . O . P . (mmHg ) ANTERIOR ANGLE PU PIL SIZE (mm ) OTHER 
A COMPARATIVE STUDY 
OF 
0-T-C TOPICAL OPHTHALMIC DECONGESTANTS 
NAME : AGE : SEX : 
�-....... ��----...---------.._- ------ ------
Drug ins tillation s chedule : Two drops are to be placed in the lower conjunctival 
sack as instructed three times a day. The first upon rising, the second following 
measurements on measurement days and the third prior to retiring in the evening . 
'l'o - �l�?W for data collection and analysis ,  be sure to record the exact time of e ach 
instillation . 
• 
DATE MORNING AFI'ERNOON � EVENING COMMENTS 
- -
� 
HUMAI� SUBJECT RELEASE FORM 
1 .  Institution 
A. Title of Proj ect : "Getting the RED out or Hey ! - White Eyes --- A 
Study of Non-Perscription Ocular Decongestants " 
B .  Principle Investigators : Kim J .  Butler 
James P. Thompson 
C .  Advis or ;  Dr . Diane Yolton 
D .  Location : Pacific University College of Optometry 
E. Date : 1977 
2 .  Des cription of Project 
This proj ect is an investi gation into the changes in the physiological state 
of the eye induced by commonly available over-the-counter topical ophthalmi c 
decongestants . The measured changes in the eye I . O . P . ,  state of mydriasi s  
and anterior angle will be used as the indeces o f  change . All eye drops will 
be self induced in a pers cribed manner . All changes in eye state will be 
s tatistically compaired drug to drug to determine if a significant difference 
exi sts . 
J .  Decripti on of Risks 
The only problems reported with these drugs as cited in the literature were 
slight s tinging s ensation upon instillation in a small percentage of people 
and extrearnly rare instances of acute angle closure glaucoma attacks in 
narrow angle glaucoma patients . The initial subj ect s creening will s elect 
out all people with narrow angles and known glaucoma thus minimizing to the 
extream any possibility of an attack of angle closure glaucoma. 
4 .  Des cription of Benefits 
5.  
This study will serve t o  detennine whi ch of the commonly used 0-T-p decongest­
ants , if any, produce the least changes in eye physi ology. It will also s erve 
as a well controlled experiment to either document and support commonly made 
claim'3 of no s i gnificant changes in eye state with use of these drugs or 
find otherwi s e . 
Alternatives Advantageous to Subjects 
They will now know the best method of eye drop instillation . 
given free of charge three types of ocular decongestants and 
tear preparation . 
They will be 
an artificial 
6 .  Offer t o  Answer any Inquiries 
The experimenter will be happy to answer any questions that you may have 
at any time during the course of this study . 
7 .  Freedom to Withdraw 
You are free to withdraw your cons ent and to discontinue participation in 
this proj ect or activity at any time without prejudice to you . 
I have read and understand the above . I am 1 8  years of age or over. 
